Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation

Auteur(s): Amat Santos, Ignacio J.Rodés-Cabau, JosepUrena Alcazar, MarinaDeLarochellière, RobertDoyle, DanielBagur, Rodrigo HernanVilleneuve, JacquesCôté, MélanieNombela-Franco, LuisPhilippon, FrançoisPibarot, PhilippeDumont, Éric
Résumé: Objectives: This study sought to evaluate the incidence, predictive factors, and prognostic value of new-onset atrial fibrillation (NOAF) following transcatheter aortic valve implantation (TAVI). Background: Very few data exist on the occurrence of NOAF following TAVI. Methods: A total of 138 consecutive patients with no prior history of atrial fibrillation (AF) underwent TAVI with a balloon-expandable valve. Patients were on continuous electrocardiogram monitoring until hospital discharge, and NOAF was defined as any episode of AF lasting >30 s. All clinical, echocardiographic, procedural, and follow-up data were prospectively collected. Results: NOAF occurred in 44 patients (31.9%) at a median time of 48 h (interquartile range: 0 to 72 h) following TAVI. The predictive factors of NOAF were left atrial (LA) size (odds ratio [OR]: 1.21 for each increase in 1 mm/m2, 95% confidence interval [CI]: 1.09 to 1.34, p < 0.0001) and transapical approach (OR: 4.08, 95% CI: 1.35 to 12.31, p = 0.019). At 30-day follow-up, NOAF was associated with a higher rate of stroke/systemic embolism (13.6% vs. 3.2%, p = 0.021, p = 0.047 after adjustment for baseline differences between groups), with no differences in mortality rate between groups (NOAF: 9.1%, no-NOAF: 6.4%, p = 0.57). At a median follow-up of 12 months (interquartile range: 5 to 20 months), a total of 27 patients (19.6%) had died, with no differences between the NOAF (15.9%) and no-NOAF (21.3%) groups, p = 0.58. The cumulative rate of stroke and stroke/systemic embolism at follow-up were 13.6% and 15.9%, respectively, in the NOAF group versus 3.2% in the no-NOAF group (p = 0.039, adjusted p = 0.037 for stroke; p = 0.020, adjusted p = 0.023 for stroke/systemic embolism). Conclusions: NOAF occurred in about one-third of the patients with no prior history of AF undergoing TAVI and its incidence was increased in patients with larger LA size and those undergoing transapical TAVI. NOAF was associated with a higher rate of stroke/systemic embolism, but not a higher mortality, at 30 days and at 1-year follow-up.
Type de document: Article de recherche
Date de publication: 10 janvier 2012
Date de la mise en libre accès: Accès restreint
Version du document: VoR
Lien permanent: http://hdl.handle.net/20.500.11794/7788
Ce document a été publié dans: Journal of the American College of Cardiology, Vol. 59 (2), 178-188 (2012)
https://doi.org/10.1016/j.jacc.2011.09.061
Elsevier
Autre version disponible: 10.1016/j.jacc.2011.09.061
22177537
Collection :Articles publiés dans des revues avec comité de lecture

Fichier(s) :
Description TailleFormat 
Amat-Santos2012-13056.pdf
1.18 MBAdobe PDF    Demander une copie
Tous les documents dans CorpusUL sont protégés par la Loi sur le droit d'auteur du Canada.